November 26, 2012

Stem Cell Research for Alzheimer's - Dr. Frank LaFerla

Thumbnail

Stem Cell Research for Alzheimer's - Dr. Frank LaFerla

About This Episode

Dr. Frank LaFerla is Director of the Institute for Memory Impairments and Neurological Disorders, University of California, Irvine. He was the first to use stem cell technology for use in mice engineered for both the plaques and tangles that are characteristic of human Alzheimer’s disease. Recently, his group reported data that shows that neural stem cells can rescue – and actually restore – memory and function in mice which have Alzheimer’s-like cognitive deficits. During this call he discusses his research and answers questions.

Dr. LaFerla was introduced by Dr. Diane Bovenkamp, Science Communications Specialist at American Health Assistance Foundation, AHAF, which funds some of his work.

This call was made possible by the generous support of the Zickler Family Foundation.

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW